Merit Medical Systems, Inc. Announces Earning Guidance for Year 2022
February 24, 2022 at 04:45 pm EST
Share
Merit Medical Systems, Inc. announced earning guidance for year 2022. For the year, company expects net sales to be in the range of $1.117 billion to $1.140 billion, net income (GAAP) to be in the range of $75.4 million to $84.0 million and diluted earnings per share GAAP to be in the range of $1.30 to $1.45.
Merit Medical Systems, Inc. designs, develops, manufactures, markets and sells medical products for interventional and diagnostic procedures. The Company is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Its cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions and original equipment manufacturer. Within these product categories, it sells a variety of products, including cardiology and radiology devices, as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care and others. Its endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors.
MERIT MEDICAL SYSTEMS, INC. 
